Exclusive: AstraZeneca to supply 31 million COVID-19 shots to EU in first quarter, a 60% cut - EU source

By Francesco Guarascio and Ludwig Burger BRUSSELS (Reuters) - AstraZeneca Plc has informed European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due to production problems, a senior official told Reuters.

Reuters January 23, 2021 03:11:03 IST
Exclusive: AstraZeneca to supply 31 million COVID-19 shots to EU in first quarter, a 60% cut - EU source

COVID-19 shots to EU in first quarter, a 60% cut - EU source" src="https://images.firstpost.com/wp-content/uploads/reuters/01-2021/23/2021-01-22T195936Z_1_LYNXMPEH0L1GG_RTROPTP_2_HEALTH-CORONAVIRUS-ASTRAZENECA-EU.jpg" alt="Exclusive AstraZeneca to supply 31 million COVID19 shots to EU in first quarter a 60 cut EU source" width="300" height="225" />

By Francesco Guarascio and Ludwig Burger

BRUSSELS (Reuters) - AstraZeneca Plc has informed European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due to production problems, a senior official told Reuters.

The decrease deals another blow to Europe's COVID-19 vaccination drive after Pfizer Inc and partner BioNTech SE slowed supplies of their vaccine to the bloc this week, saying the move was needed because of work to ramp up production.

AstraZeneca was expected to deliver about 80 million doses to the 27 EU countries by the end of March, the official who was involved in the talks said.

The official added AstraZeneca planned to begin deliveries to the EU from Feb. 15, in line with original plans.

The company confirmed the drop in deliveries without giving specific details on the magnitude of the shortfall.

"Initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain," an AstraZeneca spokesman said in a written statement.

"We will be supplying tens of millions of doses in February and March to the European Union, as we continue to ramp up production volumes," he said of the vaccine developed with Oxford University.

The Britain-based drugmaker had also agreed to deliver more than 80 million doses in the second quarter. On Friday, the EU official, who spoke under condition of anonymity, said the company was not able to provide updated delivery targets for the April to June period due to the production issues.

AstraZeneca told EU officials at a meeting that the cut was due to production problems at a vaccine factory in Belgium run by its partner Novasep, the EU official said. Novasep was not immediately available to comment.

EU governments "expressed deep dissatisfaction with this," EU Health Commissioner Stella Kyriakides said on Twitter after the announcement.

The EU drug regulator is due to decide on approval of AstraZeneca's vaccine on Jan. 29. It has already received emergency authorisation in Britain.

The EU has a deal to purchase at least 300 million doses from AstraZeneca, with an option for an additional 100 million, part of the company's global commitments to supply more than 3 billion doses.

(Reporting by Francesco Guarascio in Brussels; additional reporting by Ludwig Burger in Frankfurt; Editing by Chris Reese and Bill Berkrot)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Thyssenkrupp ends talks with UK's Liberty on steel unit sale
Business

Thyssenkrupp ends talks with UK's Liberty on steel unit sale

By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo
Business

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo

(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.

Brent gives up gains after rising above $65 on Texas freeze
Business

Brent gives up gains after rising above $65 on Texas freeze

By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.